dehydroepiandrosterone has been researched along with Urogenital Prolapse in 1 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowakowski, Ł | 1 |
| Gałczyński, K | 1 |
| Dybowski, M | 1 |
| Typek, R | 1 |
| Dawidowicz, A | 1 |
| Miotła, P | 1 |
| Olcha, P | 1 |
| Rechberger, T | 1 |
1 trial available for dehydroepiandrosterone and Urogenital Prolapse
| Article | Year |
|---|---|
Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgery.
Topics: Anti-Bacterial Agents; Dehydroepiandrosterone; Estradiol; Female; Humans; Pelvic Organ Prolapse; Sup | 2023 |